Trifluoromethyl arylamides with antileukemia effect and intracellular inhibitory activity over serine/arginine-rich protein kinases (SRPKs).

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European journal of medicinal chemistry

• Publication date

  2017-07-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2017.03.078PMID 28407594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic targeting of splicing in cancer

  2016cited by this paper
• Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives.

  2016cited by this paper
• Combination effect of therapies targeting the PI3K- and AR-signaling pathways in prostate cancer

  2016cited by this paper
• Small-molecule kinase inhibitors: an analysis of FDA-approved drugs.

  2016cited by this paper
• SRPK2 promotes the growth and migration of the colon cancer cells.

  2016cited by this paper
• Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)

  2015cited by this paper
• Splicing Regulators and Their Roles in Cancer Biology and Therapy

  2015cited by this paper
• Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant.

  2015cited by this paper
• Identification of a Dual Inhibitor of SRPK1 and CK2 That Attenuates Pathological Angiogenesis of Macular Degeneration in Mice

  2015cited by this paper
• Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma

  2014cited by this paper
• Inhibition of mTOR-Dependent Autophagy Sensitizes Leukemic Cells to Cytarabine-Induced Apoptotic Death

  2014cited by this paper
• A theoretical study of SRPK interaction with the flexible domains of hepatitis B capsids.

  2014cited by this paper
• SERINE ARGININE PROTEIN KINASE-1 (SRPK1) INHIBITION AS A POTENTIAL NOVEL TARGETED THERAPEUTIC STRATEGY IN PROSTATE CANCER

  2014cited by this paper
• Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events

  2014cited by this paper
• Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMD.

  2013cited by this paper
• SRPK1 Dissimilarly Impacts on the Growth, Metastasis, Chemosensitivity and Angiogenesis of Glioma in Normoxic and Hypoxic Conditions

  2013cited by this paper
• Isolated pseudo–RNA-recognition motifs of SR proteins can regulate splicing using a noncanonical mode of RNA recognition

  2013cited by this paper
• OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis.

  2013cited by this paper
• Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia

  2013cited by this paper
• SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularization in a rat model of retinopathy of prematurity.

  2013cited by this paper
• Regulation of splicing by SR proteins and SR protein-specific kinases

  2013cited by this paper
• An RS Motif within the Epstein-Barr Virus BLRF2 Tegument Protein Is Phosphorylated by SRPK2 and Is Important for Viral Replication

  2013cited by this paper
• The Kinase Inhibitor SFV785 Dislocates Dengue Virus Envelope Protein from the Replication Complex and Blocks Virus Assembly

  2011cited by this paper
• Serine‐arginine protein kinases: a small protein kinase family with a large cellular presence

  2011cited by this paper
• WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.

  2011cited by this paper
• Inhibition of Hepatitis C Virus Replication by a Specific Inhibitor of Serine-Arginine-Rich Protein Kinase

  2010cited by this paper
• Drug combination studies and their synergy quantification using the Chou-Talalay method.

  2010cited by this paper
• Serine/arginine protein-specific kinase 2 promotes leukemia cell proliferation by phosphorylating acinus and regulating cyclin A1.

  2008cited by this paper
• Apoptosis: A Review of Programmed Cell Death

  2007cited by this paper
• Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas.

  2007cited by this paper
• Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma.

  2006cited by this paper
• Utilization of host SR protein kinases and RNA-splicing machinery during viral replication.

  2006cited by this paper
• SR proteins: a conserved family of pre-mRNA splicing factors.

  1992cited by this paper

• Design of a covalent protein-protein interaction inhibitor of SRPKs to suppress angiogenesis and invasion of cancer cells

  2024cites this paper
• Novel diamides inspired by protein kinase inhibitors as anti-Trypanosoma cruzi agents: in vitro and in vivo evaluations.

  2023cites this paper
• First evidence of a serine arginine protein kinase (SRPK) in leishmania braziliensis and its potential as therapeutic target.

  2022cites this paper
• MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core.

  2022cites this paper
• Immunomodulatory activity of trifluoromethyl arylamides derived from the SRPK inhibitor SRPIN340 and their potential use as vaccine adjuvant.

  2022cites this paper
• Splicing dysregulation in human hematologic malignancies: beyond splicing mutations.

  2022cites this paper
• Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment

  2022cites this paper
• The SRPK inhibitor N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl) isonicotinamide (SRPIN340) increases the immune response against metastatic melanoma in mice.

  2022cites this paper
• Tandem C/N-Difunctionalization of Nitroarenes: Reductive Amination and Annulation by a Ring Expansion/Contraction Sequence.

  2022cites this paper
• Oncogenic dysregulation of pre‐mRNA processing by protein kinases: challenges and therapeutic opportunities

  2021cites this paper
• MiR-155 Inhibits Malignant Biological Behavior of Human Liver Cancer Cells by Regulating SRPK1

  2021cites this paper
• Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities

  2021cites this paper
• Leishmanicidal and cytotoxic activities and 4D‐QSAR of 2‐arylidene indan‐1,3‐diones

  2021cites this paper
• One‐Pot, Multi‐Component Synthesis of Novel 2‐Amino‐[1,2,4]triazolo[1,5‐ a ]pyrimidine‐6‐carboxamide Derivatives as Antiproliferative Agents

  2021cites this paper
• Combined SRPK and AKT pharmacological inhibition is synergistic in T-cell acute lymphoblastic leukemia cells.

  2020cites this paper
• Effect of the topical administration of N-(2-(4-bromophenylamino)-5-(trifluoromethyl)phenyl)nicotinamide compound in a murine subcutaneous melanoma model

  2020cites this paper
• Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer

  2020cites this paper
• Copper-catalyzed ortho-C(sp2)-H amination of benzamides and picolinamides with alkylamines using oxygen as a green oxidant.

  2020cites this paper
• Serine/arginine protein‐specific kinase 2 promotes the development and progression of pancreatic cancer by downregulating Numb and p53

  2019cites this paper
• Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives

  2019cites this paper
• Insights into the full-length SRPK2 structure and its hydrodynamic behavior.

  2019cites this paper
• Antimetastatic effect of the pharmacological inhibition of serine/arginine‐rich protein kinases (SRPK) in murine melanoma

  2018cites this paper
• SRPK1 is a poor prognostic indicator and a novel potential therapeutic target for human colorectal cancer

  2018cites this paper
• Serine / arginine ( SR )-rich-specific-protein kinase 2 promotes the epithelial-mesenchymal transition by upregulating Twist-related protein 1 expression in colon cancer cells

  2018cites this paper
• srPK1 is a poor prognostic indicator and a novel potential therapeutic target for human colorectal cancer

  2018cites this paper
• srPK1 is a poor prognostic indicator and a novel potential therapeutic target for human colorectal cancer

  2018cites this paper
• Targeting splice factor kinases in chronic myeloid leukaemia

  2017cites this paper